15-50748601-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000261854.10(SPPL2A):c.360+87A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 893,232 control chromosomes in the GnomAD database, including 61,960 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.40 ( 12900 hom., cov: 32)
Exomes 𝑓: 0.36 ( 49060 hom. )
Consequence
SPPL2A
ENST00000261854.10 intron
ENST00000261854.10 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.146
Genes affected
SPPL2A (HGNC:30227): (signal peptide peptidase like 2A) This gene encodes a member of the GXGD family of aspartic proteases, which are transmembrane proteins with two conserved catalytic motifs localized within the membrane-spanning regions, as well as a member of the signal peptide peptidase-like protease (SPPL) family. This protein is expressed in all major adult human tissues and localizes to late endosomal compartments and lysosomal membranes. A pseudogene of this gene also lies on chromosome 15. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-50748601-T-C is Benign according to our data. Variant chr15-50748601-T-C is described in ClinVar as [Benign]. Clinvar id is 2688411.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.558 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPPL2A | NM_032802.4 | c.360+87A>G | intron_variant | ENST00000261854.10 | NP_116191.2 | |||
SPPL2A | XM_005254722.4 | c.360+87A>G | intron_variant | XP_005254779.1 | ||||
SPPL2A | XM_017022680.2 | c.360+87A>G | intron_variant | XP_016878169.1 | ||||
SPPL2A | XM_017022681.2 | c.360+87A>G | intron_variant | XP_016878170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPPL2A | ENST00000261854.10 | c.360+87A>G | intron_variant | 1 | NM_032802.4 | ENSP00000261854 | P1 | |||
ENST00000558317.1 | n.123-1047T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.403 AC: 61197AN: 151836Hom.: 12870 Cov.: 32
GnomAD3 genomes
AF:
AC:
61197
AN:
151836
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.359 AC: 265937AN: 741278Hom.: 49060 AF XY: 0.357 AC XY: 136159AN XY: 381060
GnomAD4 exome
AF:
AC:
265937
AN:
741278
Hom.:
AF XY:
AC XY:
136159
AN XY:
381060
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.403 AC: 61275AN: 151954Hom.: 12900 Cov.: 32 AF XY: 0.403 AC XY: 29895AN XY: 74270
GnomAD4 genome
AF:
AC:
61275
AN:
151954
Hom.:
Cov.:
32
AF XY:
AC XY:
29895
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1583
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 45. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at